Title/1. Information to get
Text/
• EKG

• MAPLES

• Bedside blood tests

• If suspected tissue breakdown: CK, myoglobin, Calcium, Phosphate, Urate


Title/2. Calcium?
Text/
Indication: K > 6.0 mmol/L AND one of following:
• wide QRS
• bradycardia
• arrhythmia

Risk: tissue necrosis if Calcium Chloride 10% extravasates; use central venous catheter or large-bore antecubital peripheral venous catheter

• Calcium Gluconate 10% 30 ml (0.3 ml/kg) IV over 5 min
	OR
• Calcium Chloride 10% 10 ml (0.1 ml/kg) IV over 5 min

• Repeat after 10 min if EKG indications persist



Title/3. Insulin/Glucose?
Text/
Indication: K > 6.0 mmol/L

• Short acting insulin (e.g. Novorapid) 10 U in Glucose 50 mg/ml 500 ml IV over 15 min

• If significant hyperglycemia: 10 U in 100 ml 0.9% NaCl IV over 15 min 

• If initial Glucose < 7 mmol/L: Glucose 50 mg/ml 500 ml IV over 5 hours to prevent hypoglycemia

• Child: 0.1 U/kg with D25W infusion 2 ml/kg




Title/4. Beta-2 Agonist?
Text/
Indication: K > 6.5 mmol/L

• Salbutamol (Albuterol) 10-20 mg nebulized
	OR
• Terbutalin (Bricanyl) 0.5 mg/ml 1 ml SC

• Child < 25 kg: Salbutamol 2.5 mg nebulized

• Child 25-50 kg: Salbutamol 5 mg nebulized



Title/5. Potassium binder?
Text/
Indication: K > 6.0 mmol/L

• Sodium zirconium cyclosilicate (Lokelma) 10 g x3/day PO
OR
• Patiromer 8.4 g/day PO
OR
• Calcium Resonium 15 g x3/day PO



Title/6. Hemodialysis?
Text/
Indications:
• life-threatening hyperkalemia
• hyperkalemia resistent to medical therapy
• end-stage renal disease
• oliguric acute kidney injury (< 400 mL urine/day)
• marked tissue breakdown (e.g. rhabdomyolysis)



Title/7. Loop diuretics?
Text/
Indication: sufficient renal function

• Furosemide 40-80 mg IV in conjunction with 0.9% NaCl infusion



Title/8. Further Management
Text/
• Remeasure Potassium and Glucose 2 hours after start of therapy

• Address cause of hyperkalemia (e.g.discontinue medications, Foley catheter)